A long term experimental study of canine visceral leishmaniasis (original) (raw)

Abstract

Previous studies on Leishmania infantum and the canine immune response are derived mainly from short-term studies. To date, there have been no longitudinal studies that perform a serial analysis of the intensity of infection in conjunction with immunological parameters and clinical signs in Leishmania-infected dogs. For this purpose, six dogs were infected experimentally by the i.v. route and were monitored for 1 year. Clinical, immunological (humoral and cellular response) and parasitological (parasitaemia) parameters were evaluated monthly. Four dogs developed clinico-pathological signs compatible with leishmaniasis, whereas two dogs showed few abnormalities during the study. Evaluation of clinical, immunological and parasitological parameters showed that the intensity of Leishmania infection in blood samples, as indicated by the amount of Leishmania DNA, was correlated significantly with IgG, IgG1, IgG2, IgA, and IgM concentrations and with clinical signs. Parasitaemia and Leishmania-specific cell-mediated immunity were inversely correlated. Moreover, higher quantities of Leishmania DNA were detected in the liver, spleen, lymph node, skin and bone marrow of dogs exhibiting clinical signs than those exhibiting few such signs. These findings suggest that progressive disease in experimental canine leishmaniasis is associated with specific T-cell unresponsiveness and unprotective humoral responses which allow the dissemination and multiplication of L. infantum in different tissues. Ó

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (51)

  1. Alberola, J., Rodriguez, A., Francino, O., Roura, X., Rivas, L., Andreu, D., 2004. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. J. Antimicrob. Chemother. 48, 641-643.
  2. Altet, L., Francino, O., Solano-Gallego, L., Renier, C., Sanchez, A., 2002. Mapping and sequencing of the canine NRAMP1 gene and identifi- cation of mutations in leishmaniasis-susceptible dogs. Infect. Immun. 70, 2763-2771.
  3. Berrahal, F., Mary, C., Roze, M., Berenger, A., Escoffier, K., Lamouroux, D., Dunan, S., 1996. Canine leishmaniasis: identification of asymp- tomatic carriers by polymerase chain reaction and immunoblotting. Am. J. Trop. Med. Hyg. 55, 273-277.
  4. Borja-Cabrera, G., Correia Pontes, N., da Silva, V., Paraguai de Souza, E., Santos, W., Gomes, E., Luz, K., Palatnik, M., Palatnik de Sousa, C., 2002. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Gonc ¸alo do Amarante, RN). Vaccine 20, 3277-3284.
  5. Bossolasco, S., Gaiera, G., Olchini, D., Gulletta, M., Martello, L., Bestetti, A., Bossi, L., Germagnoli, L., Lazzarin, A., Uberti-Foppa, C., Cinque, P., 2003. Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leish- maniasis. J. Clin. Microbiol. 41, 5080-5084.
  6. Bourdoiseau, G., Bonnefont, C., Hoareau, E., Boehringer, C., Stolle, T., Chabanne, L., 1997. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Vet. Immunol. Immunopathol. 59, 21-30.
  7. Bo ¨yum, A., 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21, 77-89.
  8. Bretagne, S., Durand, R., Olivi, M., Garin, J.F., Sulahian, A., Rivollet, D., Vidaud, M., Deniau, M., 2001. Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin. Diagn. Lab. Immunol. 8, 828-831.
  9. Cabral, M., O'Grady, J.E., Gomes, S., Sousa, J.C., Thompson, H., Alexander, J., 1998. The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs. Vet. Parasitol. 76, 173-180.
  10. Cardoso, L., Neto, F., Sousa, J.C., Rodrigues, M., Cabral, M., 1998. Use of leishmanin skin test in the detection of canine Leishmania-specific cellular immunity. Vet. Parasitol. 79, 213-220.
  11. Courtenay, O., Quinnell, R., Garcez, L., Shaw, J., Dye, C., 2002. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J. Infect. Dis. 186, 1314-1320.
  12. Deplazes, P., Smith, N.C., Arnold, P., Lutz, H., Eckert, J., 1995. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Parasite Immunol. 17, 451-458.
  13. Engwerda, C.R., Kaye, P.M., 2000. Organ-specific immune responses associated with infectious disease. Immunol. Today 21, 73-78.
  14. Fernandez-Bellon, H., Solano-Gallego, L., Rodriguez, A., Rutten, V.P., Hoek, A., Ramis, A., Alberola, J., Ferrer, L., 2005. Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs. Vet. Immunol. Immunopathol. 107, 163-169.
  15. Fisa, R., Gallego, M., Castillejo, S., Aisa, M.J., Serra, T., Riera, C., Carrio, J., Gallego, J., Portus, M., 1999. Epidemiology of canine leishmaniosis in catalonia (Spain) the example of the priorat focus. Vet. Parasitol. 83, 87-97.
  16. Francino, O., Altet, L., Sanchez-Robert, E., Rodriguez, A., Solano- Gallego, L., Alberola, J., Ferrer, L., Sanchez, A., Roura, X., 2006. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet. Parasitol. 137, 214-221.
  17. Guarga, J., Moreno, J., Lucientes, J., Gracia, M., Peribanez, M., Castillo, J., 2002. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis. Vet. Immunol. Immunopa- thol. 88, 13-20.
  18. Kaye, P.M., Curry, A.J., Blackwell, J.M., 1991. Differential production of Th1-and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leish- maniasis. J. Immunol. 146, 2763-2770.
  19. Killick-Kendrick, R., Killick-Kendrick, M., Pinelli, E., Del Real, G., Molina, R., Vitutia, M., Can ˜avate, M.C., Nieto, J., 1994. A laboratory model of canine leishmaniasis: the inoculation of dogs with Leishmania infantum promastigotes from midguts of experimentally infected phlebotomine sandflies. Parasite 1, 311-318.
  20. Leandro, C., Santos-Gomes, G.M., Campino, L., Romao, P., Cortes, S., Rolao, N., Gomes-Pereira, S., Ric ¸a Capela, M.J., Abranches, P., 2001. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis. Vet. Immunol. Immunopathol. 79, 273-284.
  21. Lemesre, J.L., Holzmuller, P., Cavaleyra, M., Goncalves, R.B., Hottin, G., Papierok, G., 2005. Protection against experimental visceral leishman- iasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23, 2825-2840.
  22. Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408.
  23. Martinez-Moreno, A., Moreno, T., Martinez-Moreno, F.J., Acosta, I., Hernandez, S., 1995. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. Vet. Immunol. Immunopathol. 48, 209-220.
  24. Mathis, A., Deplazes, P., 1995. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J. Clin. Microbiol. 33, 1145-1149.
  25. Molano, I., Alonso, M., Miron, C., Redondo, E., Requena, J., Soto, M., Nieto, C., Alonso, C., 2003. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Vet. Immunol. Immunopa- thol. 92, 1-13.
  26. Moreno, J., Alvar, J., 2002. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 18, 399-405.
  27. Moreno, J., Nieto, J., Chamizo, C., Gonzalez, F., Blanco, F., Barker, D.C., Alva, J., 1999. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Vet. Immunol. Immunopathol. 71, 181-195.
  28. Pennisi, M.G., Reale, S., Giudice, S.L., Masucci, M., Caracappa, S., Vitale, M., Vitale, F., 2005. Real-time PCR in dogs treated for leishmaniasis with allopurinol. Vet. Res. Commun. 29, 301-303.
  29. Pinelli, E., Killick-Kendrick, R., Wagenaar, J., Bernadina, W., del Real, G., Ruitenberg, J., 1994. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62, 229-235.
  30. Pinelli, E., Rutten, V.P.M.G., Bruysters, M., Moore, P.F., Ruitenberg, E.J., 1999. Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restora- tion of parasite-specific T-cell proliferation and gamma interferon production. Infect. Immun. 67, 237-243.
  31. Poot, J., Rogers, M.E., Bates, P.A., Vermeulen, A., 2005. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Vet. Parasitol. 130, 41-53.
  32. Quinnell, R.J., Courtenay, O., Davidson, S., Garcez, L., Lambson, B., Ramos, P., Shaw, J.J., Shaw, M.A., Dye, C., 2001. Detection of Leishmania infantum by PCR, serology and cellular immune response in a cohort study of Brazilian dogs. Parasitology 122, 253-261.
  33. Quinnell, R.J., Kennedy, L.J., Barnes, A., Courtenay, O., Dye, C., Garcez, L.M., Shaw, M.A., Carter, S.D., Thomson, W., Ollier, W.E., 2003. Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Immunogenetics 55, 23-28.
  34. Ramiro, M., Zarate, J., Hanke, T., Rodriguez, D., Rodriguez, J., Esteban, M., Lucientes, J., Castillo, J., Larraga, V., 2003. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine 21, 2474-2484.
  35. Reis, A.B., Martins-Filho, O.A., Teixeira-Carvalho, A., Carvalho, M.G., Mayrink, W., Franca-Silva, J.C., Giunchetti, R.C., Genaro, O., Correa-Oliveira, R., 2005. Parasite density and impaired biochemi- cal/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Res. Vet. Sci. 81, 68-75.
  36. Reis, A.B., Teixeira-Carvalho, A., Vale, A.M., Marques, M.J., Giunchetti, R.C., Mayrink, W., Guerra, L.L., Andrade, R.A., Correa-Oliveira, R., Martins-Filho, O.A., 2006. Isotype patterns of immunoglobulins: Hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Vet. Immunol. Immunopathol. 112, 102-116.
  37. Requena, J.M., Soto, M., Doria, M.D., Alonso, C., 2000. Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet. Immunol. Immunopathol. 76, 269-281.
  38. Rhalem, A., Sahibi, H., Guessous-Idrissi, N., Lasri, S., Natami, A., Riyad, M., Berrag, B., 1999. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. Vet. Parasitol. 81, 173-184.
  39. Rica-Capela, M., Cortes, S., Leandro, C., Peleteiro, M., Santos-Gomes, G., Campino, L., 2003. Immunological and histopathological studies in a rodent model infected with Leishmania infantum promastigotes or amastigotes. Parasitol. Res. 89, 163-169.
  40. Rodrı ´guez, A., Solano-Gallego, L., Ojeda, A., Quintana, J., Riera, C., Ga ´llego, M., Portu ´s, M., Alberola, J., 2006. Dynamics of Leishmania- specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment. J. Vet. Int. Med. 20, 495-498.
  41. Sanchez, M.A., Diaz, N.L., Zerpa, O., Negron, E., Convit, J., Tapia, F.J., 2004. Organ-specific immunity in canine visceral leishmani- asis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. Am. J. Trop. Med. Hyg. 70, 618-624.
  42. Satti, I., el Hassan, A., Khalil el, T.A., Akuffo, H., 2002. The effect of repeated leishmanin skin testing on the immune responses to Leish- mania antigen in healthy volunteers. Trans. R. Soc. Trop. Med. Hyg. 96, 565-567.
  43. Sideris, V., Papadopoulou, G., Dotsika, E., Karagouni, E., 1999. Asymptomatic canine leishmaniasis in Greater Athens area, Greece. Eur. J. Epidemiol. 15, 271-276.
  44. Slappendel, R.J., 1988. Canine leishmaniasis: A review based on 95 cases in the Netherlands. Vet. Q. 10, 1-16.
  45. Solano-Gallego, L., Llull, J., Ramos, G., Riera, C., Arboix, M., Alberola, J., Ferrer, L., 2000. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Vet. Parasitol. 90, 37-45.
  46. Solano-Gallego, L., Morell, P., Arboix, M., Alberola, J., Ferrer, L., 2001a. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J. Clin. Microbiol. 39, 560-563.
  47. Solano-Gallego, L., Riera, C., Roura, X., Iniesta, L., Gallego, M., Valladares, J.E., Fisa, R., Castillejo, S., Alberola, J., Ferrer, L., Arboix, M., Portus, M., 2001b. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Vet. Parasitol. 96, 265-276.
  48. Steuber, S., Moritz, A., Schirrmann, I., Greiner, M., 1998. PCR follow-up examination after treatment of canine leishmaniosis (CaL). Tokai J. Exp. Clin. Med. 23, 285-292.
  49. Travi, B.L., Tabares, C.J., Cadena, H., Ferro, C., Osorio, Y., 2001. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies. Am. J. Trop. Med. Hyg. 63, 119-124.
  50. Valladares, J.E., Riera, C., Alberola, J., Gallego, M., Portus, M., Cristofol, C., Franquelo, C., Arboix, M., 1998. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Vet. Parasitol. 75, 33-40.
  51. Weigle, K.A., Valderrama, L., Arias, A.L., Santrich, C., Saravia, N.G., 1991. Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am. J. Trop. Med. Hyg. 44, 260-271.